Your browser doesn't support javascript.
loading
Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation.
Shah, R J; Diamond, J M; Cantu, E; Flesch, J; Lee, J C; Lederer, D J; Lama, V N; Orens, J; Weinacker, A; Wilkes, D S; Roe, D; Bhorade, S; Wille, K M; Ware, L B; Palmer, S M; Crespo, M; Demissie, E; Sonnet, J; Shah, A; Kawut, S M; Bellamy, S L; Localio, A R; Christie, J D.
Afiliação
  • Shah RJ; Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Diamond JM; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Cantu E; Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Flesch J; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Lee JC; Division of Cardiovascular Surgery, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Lederer DJ; Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Lama VN; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Orens J; Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Weinacker A; Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY.
  • Wilkes DS; Division of Pulmonary, Allergy, and Critical Care Medicine, University of Michigan, Ann Arbor, MI.
  • Roe D; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, MD.
  • Bhorade S; Department of Pulmonary and Critical Care, Stanford University, Palo Alto, CA.
  • Wille KM; Division of Pulmonary, and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, IN.
  • Ware LB; Division of Pulmonary, and Critical Care Medicine, Indiana University School of Medicine, Indianapolis, IN.
  • Palmer SM; Division of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL.
  • Crespo M; Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Demissie E; Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Sonnet J; Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University, Durham, NC.
  • Shah A; Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh, Pittsburgh, PA.
  • Kawut SM; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA.
  • Bellamy SL; Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY.
  • Localio AR; Department of Surgery, Johns Hopkins University Hospital, Baltimore, MD.
  • Christie JD; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA.
Am J Transplant ; 15(8): 2188-96, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25877792
ABSTRACT
Primary graft dysfunction (PGD) is a major cause of early mortality after lung transplant. We aimed to define objective estimates of PGD risk based on readily available clinical variables, using a prospective study of 11 centers in the Lung Transplant Outcomes Group (LTOG). Derivation included 1255 subjects from 2002 to 2010; with separate validation in 382 subjects accrued from 2011 to 2012. We used logistic regression to identify predictors of grade 3 PGD at 48/72 h, and decision curve methods to assess impact on clinical decisions. 211/1255 subjects in the derivation and 56/382 subjects in the validation developed PGD. We developed three prediction models, where low-risk recipients had a normal BMI (18.5-25 kg/m(2) ), chronic obstructive pulmonary disease/cystic fibrosis, and absent or mild pulmonary hypertension (mPAP<40 mmHg). All others were considered higher-risk. Low-risk recipients had a predicted PGD risk of 4-7%, and high-risk a predicted PGD risk of 15-18%. Adding a donor-smoking lung to a higher-risk recipient significantly increased PGD risk, although risk did not change in low-risk recipients. Validation demonstrated that probability estimates were generally accurate and that models worked best at baseline PGD incidences between 5% and 25%. We conclude that valid estimates of PGD risk can be produced using readily available clinical variables.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Pulmão / Disfunção Primária do Enxerto Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Pulmão / Disfunção Primária do Enxerto Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article